| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Caspase-3 |
|---|
| Ligand | BDBM50145661 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_46654 |
|---|
| IC50 | 10±n/a nM |
|---|
| Citation |  Linton, SD; Aja, T; Allegrini, PR; Deckwerth, TL; Diaz, JL; Hengerer, B; Herrmann, J; Jahangiri, KG; Kallen, J; Karanewsky, DS; Meduna, SP; Nalley, K; Robinson, ED; Roggo, S; Rovelli, G; Sauter, A; Sayers, RO; Schmitz, A; Smidt, R; Ternansky, RJ; Tomaselli, KJ; Ullman, BR; Wiessner, C; Wu, JC Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke. Bioorg Med Chem Lett14:2685-91 (2004) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Caspase-3 |
|---|
| Name: | Caspase-3 |
|---|
| Synonyms: | Apopain | CASP-3 | CASP3 | CASP3_HUMAN | CPP-32 | CPP32 | Caspase 3 | Caspase-3 subunit p12 | Caspase-3 subunit p17 | Cysteine protease CPP32 | SCA-1 | SREBP cleavage activity 1 | Yama protein | caspase-3 preproprotein |
|---|
| Type: | Hydrolase; heterotetramer of two heterodimers |
|---|
| Mol. Mass.: | 31607.55 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | n/a |
|---|
| Residue: | 277 |
|---|
| Sequence: | MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTG
MTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLS
HGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDD
DMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVN
RKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH
|
|
|
|---|
| BDBM50145661 |
|---|
| n/a |
|---|
| Name | BDBM50145661 |
|---|
| Synonyms: | (S)-3-{(S)-4-Methyl-2-[(naphthalen-1-ylaminooxalyl)-amino]-pentanoylamino}-4-oxo-butyric acid | CHEMBL90307 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C22H25N3O6 |
|---|
| Mol. Mass. | 427.4504 |
|---|
| SMILES | CC(C)C[C@H](NC(=O)C(=O)Nc1cccc2ccccc12)C(=O)N[C@@H](CC(O)=O)C=O |
|---|
| Structure | 
|
|---|
Search and Browse
